[go: up one dir, main page]

HK1114021A - Tizanidine compositions and methods of treatment using the compositions - Google Patents

Tizanidine compositions and methods of treatment using the compositions Download PDF

Info

Publication number
HK1114021A
HK1114021A HK08109540.8A HK08109540A HK1114021A HK 1114021 A HK1114021 A HK 1114021A HK 08109540 A HK08109540 A HK 08109540A HK 1114021 A HK1114021 A HK 1114021A
Authority
HK
Hong Kong
Prior art keywords
compositions
tizanidine
treatment
methods
tizanidine compositions
Prior art date
Application number
HK08109540.8A
Other languages
Chinese (zh)
Inventor
Flashner-Barak Moshe
Gavin Judelman Alon
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of HK1114021A publication Critical patent/HK1114021A/en

Links

HK08109540.8A 2005-08-01 2006-08-01 Tizanidine compositions and methods of treatment using the compositions HK1114021A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/704,731 2005-08-01
US60/819,074 2006-07-06

Publications (1)

Publication Number Publication Date
HK1114021A true HK1114021A (en) 2008-10-24

Family

ID=

Similar Documents

Publication Publication Date Title
IL233634A0 (en) Methods, compositions, and kits for the treatment of medical conditions
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
ZA200704677B (en) Compositions and methods for the treatment of autism
IL190885A0 (en) Immunogenic compositions and methods of use
IL191072A0 (en) Therapeutic compositions and methods
EP1928453A4 (en) Methods and compositions for the preventioin and treatment of kidney disease
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
WO2007101161A8 (en) Methods and compositions for the treatment of gastrointestinal disorders
WO2007081751A9 (en) Compositions and methods for the treatment of cancer
IL187405A0 (en) Methods and compositions for the treatment of pain
ZA200805711B (en) Solid biocidal compositions and methods of using the same
EP1912630A4 (en) Compositions and methods for the reduction of post-operative pain
WO2006002203A8 (en) Methods and compositions for the treatment of polycystic diseases
GB0504657D0 (en) Compositions and methods of treatment
HK1114021A (en) Tizanidine compositions and methods of treatment using the compositions
ZA200710476B (en) Methods and compositions for the treatment of pain
HK1110530A (en) Methods and compositions for the treatment of pain
AU2005904259A0 (en) Compositions and methods of treatment
AU2005903854A0 (en) Compositions and methods of treatment
AU2004902179A0 (en) Methods and Compositions for the Treatment of Myocardial Conditions
AU2005906601A0 (en) Therapeutic methods and compositions
AU2004900511A0 (en) Compositions and Methods of Treatment
AU2004904405A0 (en) Compositions and Methods of Treatment
AU2005904711A0 (en) Compositions and methods of use thereof
HK1119954A (en) Use of neboglamine in the treatment of toxicodependency